您的位置: 首页 > 农业专利 > 详情页

treatment of hepatitis c virus infections with telaprevir (vx-950) in patients unresponsive to treatment with pegylated interferon alfa-2a / 2b and ribavirin
专利权人:
VERTEX PHARMACEUTICALS INCORPORATED
发明人:
Ira Jacobson,John Mchutchison,Lindsay Mcnair
申请号:
BRPI0911673
公开号:
BRPI0911673A2
申请日:
2009.04.23
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充